
Pulse Biosciences PLSE
$ 15.08
2.41%
Quarterly report 2025-Q3
added 11-05-2025
Pulse Biosciences Total Shareholders Equity 2011-2026 | PLSE
Annual Total Shareholders Equity Pulse Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.4 M | -2.25 M | 35.7 M | 22.9 M | 30.7 M | 66.3 M | 46 M | 25.3 M | 13.7 M | 16.1 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 66.3 M | -2.25 M | 29.9 M |
Quarterly Total Shareholders Equity Pulse Biosciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92.7 M | 104 M | 118 M | 115 M | 79.1 M | 27 M | 36.3 M | 44.4 M | 52.1 M | 60.5 M | -10.7 M | -2.25 M | 6.19 M | 23.4 M | 20.8 M | 44.4 M | 47.4 M | 59.8 M | 20.4 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 30.7 M | 30.7 M | 30.7 M | 30.7 M | 66.3 M | 66.3 M | 66.3 M | 66.3 M | 46 M | 46 M | 46 M | 46 M | 25.3 M | 25.3 M | 25.3 M | 25.3 M | 13.7 M | 13.7 M | 13.7 M | 13.7 M | 16.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 118 M | -10.7 M | 40.3 M |
Total Shareholders Equity of other stocks in the Medical instruments industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M | ||
|
Baxter International
BAX
|
6.96 B | $ 20.95 | 1.21 % | $ 10.7 B | ||
|
Becton, Dickinson and Company
BDX
|
25.4 B | $ 203.51 | -0.78 % | $ 58.5 B | ||
|
Ekso Bionics Holdings
EKSO
|
12.7 M | $ 8.27 | 0.98 % | $ 167 M | ||
|
Alcon
ALC
|
18.8 B | $ 79.9 | -0.91 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
1.97 B | $ 151.28 | -0.24 % | $ 3.69 B | ||
|
AtriCure
ATRC
|
461 M | $ 42.16 | -0.58 % | $ 1.98 B | ||
|
iRhythm Technologies
IRTC
|
90.9 M | $ 187.98 | -0.67 % | $ 5.86 B | ||
|
electroCore
ECOR
|
7.44 M | $ 5.1 | 1.39 % | $ 28.1 K | ||
|
Haemonetics Corporation
HAE
|
821 M | $ 83.99 | -0.05 % | $ 4.23 B | ||
|
AngioDynamics
ANGO
|
183 M | $ 10.01 | -0.4 % | $ 409 M | ||
|
Harvard Bioscience
HBIO
|
73.1 M | $ 0.67 | 2.7 % | $ 28.4 M | ||
|
Repro Med Systems
KRMD
|
20.4 M | $ 5.81 | -0.08 % | $ 265 M | ||
|
The Cooper Companies
COO
|
8.24 B | $ 82.78 | -0.43 % | $ 16.5 B | ||
|
LeMaitre Vascular
LMAT
|
337 M | $ 85.15 | 0.13 % | $ 1.91 B | ||
|
Masimo Corporation
MASI
|
1.05 B | $ 137.3 | -0.44 % | $ 7.32 B | ||
|
Glaukos Corporation
GKOS
|
462 M | $ 113.5 | -0.63 % | $ 5.5 B | ||
|
Merit Medical Systems
MMSI
|
1.38 B | $ 89.12 | -4.36 % | $ 5.19 B | ||
|
InfuSystem Holdings
INFU
|
48 M | $ 8.97 | 0.28 % | $ 185 M | ||
|
Isoray
ISR
|
291 M | - | 0.03 % | $ 108 M | ||
|
Nephros
NEPH
|
8.36 M | $ 5.01 | - | $ 52 M | ||
|
Intuitive Surgical
ISRG
|
16.4 B | $ 587.36 | 0.39 % | $ 209 B | ||
|
Predictive Oncology
POAI
|
-203 K | $ 7.04 | 4.15 % | $ 38.4 M | ||
|
Microbot Medical
MBOT
|
4.5 M | $ 2.17 | -1.14 % | $ 22.1 M | ||
|
Milestone Scientific
MLSS
|
5.83 M | $ 0.29 | -0.75 % | $ 23.1 M | ||
|
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
2.93 B | $ 23.54 | -0.28 % | $ 4.05 B | ||
|
OraSure Technologies
OSUR
|
410 M | $ 2.65 | -0.38 % | $ 197 M | ||
|
Utah Medical Products
UTMD
|
128 M | $ 59.13 | 0.69 % | $ 215 M | ||
|
Pro-Dex
PDEX
|
36.6 M | $ 41.55 | 0.61 % | $ 137 M | ||
|
Repligen Corporation
RGEN
|
1.96 B | $ 167.44 | 0.61 % | $ 9.33 M | ||
|
ResMed
RMD
|
3.36 B | $ 251.02 | 0.04 % | $ 36.7 B | ||
|
BioLife Solutions
BLFS
|
349 M | $ 24.96 | 0.02 % | $ 1.15 B | ||
|
STERIS plc
STE
|
6.6 B | $ 260.69 | - | $ 25.7 B | ||
|
Stereotaxis
STXS
|
16.3 M | $ 2.58 | -0.19 % | $ 208 M | ||
|
Retractable Technologies
RVP
|
87.2 M | $ 0.78 | - | $ 23.4 M | ||
|
STAAR Surgical Company
STAA
|
397 M | $ 22.38 | -0.53 % | $ 1.1 B | ||
|
Teleflex Incorporated
TFX
|
4.28 B | $ 110.92 | 0.83 % | $ 5.2 B | ||
|
West Pharmaceutical Services
WST
|
2.68 B | $ 276.83 | 0.58 % | $ 20.2 B | ||
|
DENTSPLY SIRONA
XRAY
|
1.94 B | $ 12.45 | -0.36 % | $ 2.53 B |